Join in June to score a special gift!

A Pill to Treat Postpartum Depression? It’s Here

September 27, 2023

 • 

Read time:

5-15 mins
Woman Sitting Cell Pills
Presented by Health Lab

Approved by the FDA in August 2023, zuranolone (branded Zurzuvae) has been released and is the first oral medication to treat postpartum depression. Zuranolone supplies a mimic of allopregnanolone – a neurohormone that decreases significantly after pregnancy to help reverse the withdrawal effects that impact mood.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.